Quotient Bioresearch (Quotient), a leading provider of early stage and specialist drug development services, has been presented with three awards at the East Cambridgeshire Business Awards held in November. Quotient won awards in both ...
Tags: Quotient, drug development services, Quotient Bioresearch, Hat Trick
Edison Pharmaceuticals has started a phase 2B study, which will investigate new treatments for Friedreich's ataxia. The trial is entitled Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia. It is ...
Tags: Edison Pharmaceuticals, disease severity, neuromuscular function
Perrigo has signed a definitive merger agreement as well as has acquired Cobrek Pharmaceuticals, an US-based drug development company, for nearly $45m on a cash free and debt free basis. The company, in May 2008, had also acquired an ...
Tags: Perrigo, definitive merger agreement, Cobrek Pharmaceuticals
US-based Blend Therapeutics has appointed Mark Iwicki as its president, chief executive officer and a member of the board of directors. Iwicki comes with more than 23 years of experience in the pharmaceutical industry with experience in ...
Tags: Blend Therapeutics, CEO, Iwicki, drug development
US-based Omni Bio Pharmaceutical has named Bruce Schneider as the company's new chief executive officer (CEO), effective 1 January 2013. Omni Bio is involved in developing alternative uses of Alpha-1 antitrypsin (AAT), designed for ...
Tags: Pharmaceutical, New CEO, Omni Bio, AAT
PharmaNet/i3, the inVentiv Health Clinical segment, is providing the first mobile application for bioanalytical assays. The mobile application enables clients to search the company's more than 1000 bioanalytical assays from an iPhone, ...
Tags: Bioanalytical Assays, Mobile Application, PharmaNet/i3, Medicine
Poxel has raised €13m ($17m) in a series B round financing to develop and confirm efficacy data of Imeglimin, a drug used to treat type 2 diabetes. Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the ...
Tags: Poxel, efficacy data of Imeglimin, drug, ype 2 diabetes
Quintiles has completed the acquisition of Expression Analysis, a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. The acquisition will enable Quintiles' customers to use genomic ...
Tags: Quintiles, acquisition, medical service
Charles River Laboratories has inaugurated a new biomedical diagnostic testing facility in Wilmington, Massachusetts, US. The 60,000ft 2 new facility will provide controlled environments, building monitoring and mechanical systems ...
Merck Serono has entered into a collaboration agreement to provide strategic, scientific and medical support in the development and commercialization of Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) test. The Eeva test, ...
Tags: Eeva test, non-invasive computerized test, embryo selection
T2 Biosystems has announced data of its T2Hemostasis monitoring system at the 54th Annual Meeting of the American Society for Hematology (ASH) which is being held in Atlanta, Georgia, US. The system has the capability to characterize key ...
Tags: T2 Biosystems, monitoring system, key coagulation, platelet, health
StemCells has obtained US Patent for its human liver engrafting cells (hLEC), under patent number 8,283,164 titled 'Liver engrafting cells, assays and uses thereof'. Researchers of the firm have demonstrated the hLEC cells engraftment and ...
Spermatech has selected Dotmatics Platform as its central system to manage and analyse its scientific data. Spermatech, an early drug development company, identifies small molecules which can be developed into a non-hormonal male ...
Tags: Spermatech, Dotmatics Platform, manage and analyse data
NewLink Genetics HyperAcute-Pancreas Immunotherapy (algenpantucel-L) has gained European orphan designation. Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased ...
Tags: algenpantucel-L, NewLink Genetics, HyperAcute-Pancreas Immunotherapy
SQI Diagnostics has introduced SQiDlite multiplexing system for pharmaceutical drug development and contract research organizations performing bioanalytical and immunogenicity testing. The SqiDlite system, which can run on the company's ...
Tags: SQI Diagnostics, SQiDlite multiplexing system, immunogenicity testing